EUVIMEDEUVIMED entdecken
Crossref

Phosphodiesterase 2A as a Therapeutic Target for Relieving Mechanical Allodynia and Modulating Microglial Polarization in Neuropathic Pain Models Following Spinal Cord Injury

Wen-Jie Yang, Jie Han, Zhen-Xin Cao, Lei Yang, Jun-Nan Wang iD, Tao Sun

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Wen-Jie Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, Shandong Public Health Clinical Center, Jinan 250102 Shandong, China. Hauptthemen laut MEDLINE: Neuralgia, Microglia, Cyclic Nucleotide Phosphodiesterases, Type 2, Spinal Cord Injuries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Medical and Health Science and Technology Development Project of Shandong Province, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord injury (SCI) is a severe clinical condition often accompanied by multiple complications, with neuropathic pain (NP) being one of the most persistent and difficult conditions to treat. The underlying mechanisms of NP remain unclear, and effective clinical treatments are lacking. Some studies suggest that phosphodiesterase 2A (PDE2A) may contribute to the development of NP. This study aims to investigate the role of PDE2A inhibitor Bay 60-7550 in alleviating NP in a rat model of SCI. Male Sprague-Dawley rats were randomly allocated into four groups: sham, SCI, SCI + Bay 60-7550, and SCI + vehicle. Mechanical thresholds were assessed using the von Frey test from 1 day prior to surgery through postoperative day 21. PDE2A expression in the spinal cord was quantified via qRT-PCR, Western blotting, and immunohistochemistry. Microglial polarization (M1/M2) was analyzed using flow cytometry and qRT-PCR. Downstream biomarkers, including IL-6, IL-1β, IL-10, TGF-β, CCL2, and CCL3, were also quantified via qRT-PCR. Additionally, enzyme-linked immunosorbent assay (ELISA) was performed to determine the levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Intrathecal administration of the PDE2A inhibitor Bay 60-7550 significantly alleviated mechanical allodynia in rats following SCI. PDE2A expression was notably elevated in the spinal dorsal horn post-SCI, an effect that was suppressed by Bay 60-7550 treatment. In addition, Bay 60-7550 administration reduced the expression of pro-inflammatory cytokines (IL-6, IL-1β), increased anti-inflammatory cytokines (IL-10, TGF-β), and decreased mRNA levels of CCL2 and CCL3 in the spinal cord. Consistently, treatment with Bay 60-7550 elevated the levels of cGMP and cAMP in the spinal cord and shifted microglial polarization by increasing the proportion of M2-type cells while reducing M1-type cells in SCI rats. Inhibiting PDE2A overexpression may mitigate the progression of NP in rats following SCI by modulating microglial polarization. Therefore, PDE2A represents a promising therapeutic target for the management of neuropathic pain after SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaMicrogliaCyclic Nucleotide Phosphodiesterases, Type 2Spinal Cord InjuriesHyperalgesiaAnimalsMaleRats, Sprague-DawleyRatsDisease Models, AnimalSpinal CordCyclic GMP

Stichwörter der Autor:innen

microglianeuropathic painphosphodiesterase 2Apolarizationspinal cord injury

Substanzen

Cyclic Nucleotide Phosphodiesterases, Type 2Cyclic GMP

Autor:innen und Institutionen

  • Department of Anesthesiology and Perioperative Medicine, Shandong Public Health Clinical Center, Jinan 250102 Shandong, China.
  • Department of Anesthesiology, Qilu Hospital of Shandong University, Jinan 250012 Shandong, China.
  • Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021 Shandong, China.
  • Department of Pain Management, Weihai Municipal Hospital,Shandong University, Weihai, Shandong 264200, China.
  • Department of Pain Management, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021 Shandong, China.

ORCID-Profile: Jun-Nan Wang

Förderung

  • Medical and Health Science and Technology Development Project of Shandong Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Shandong Province Chinese Medicine Science and Technology Top Level Program

Zitieren

APA

Yang, W. J., Han, J., Cao, Z. X., Yang, L., Wang, J. N., & Sun, T. (2025). Phosphodiesterase 2A as a Therapeutic Target for Relieving Mechanical Allodynia and Modulating Microglial Polarization in Neuropathic Pain Models Following Spinal Cord Injury. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00169

Vancouver

Yang WJ, Han J, Cao ZX, Yang L, Wang JN, Sun T. Phosphodiesterase 2A as a Therapeutic Target for Relieving Mechanical Allodynia and Modulating Microglial Polarization in Neuropathic Pain Models Following Spinal Cord Injury. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00169

BibTeX
@article{Yang2025,
  author = {Yang, Wen-Jie and Han, Jie and Cao, Zhen-Xin and Yang, Lei and Wang, Jun-Nan and Sun, Tao},
  title = {Phosphodiesterase 2A as a Therapeutic Target for Relieving Mechanical Allodynia and Modulating Microglial Polarization in Neuropathic Pain Models Following Spinal Cord Injury},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00169}
}
Kostenlos starten →